OpenAI has introduced the Rosalind Academic Plan to help more academic scientists access GPT-Rosalind, its dedicated life sciences model. The model combines frontier reasoning with the Rosalind workbench, which enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications. Eligible labs can receive up to 30 Business Standard seats at no cost for up to 12 months, with access to GPT-Rosalind subject to trusted-access approval.
OpenAI says academic research creates knowledge that entire fields build on, and that advances in diagnosis, medicine and agriculture depend on scientists having the resources to explore, test and share their ideas. The company frames the plan as part of its mission to ensure that artificial general intelligence benefits all of humanity, investing in scientists doing foundational work.
The company points to earlier basic research as precedent. The Human Genome Project helped launch modern genomics, curiosity-driven work on bacterial immune systems led to CRISPR-Cas9, and decades of university research on mRNA laid the groundwork for COVID-19 vaccines.
The plan gives eligible labs up to 30 seats at $0 per user per month for up to 12 months, access to commercially available frontier OpenAI models subject to usage limits, and access to GPT-Rosalind after trusted-access approval. Research data shared through the plan is not used to train models by default. GPT-Rosalind supports work such as drug and protein design. The plan is currently available to academic labs at U.S. universities, and PIs without an OpenAI Enterprise agreement can apply through the trusted access process.
Source: OpenAI Blog · Summarized by HeadlinesBriefing